David Mutimer

Summary

Affiliation: University Hospital Birmingham
Country: UK

Publications

  1. ncbi request reprint Review article: hepatitis B and liver transplantation
    D Mutimer
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham University, Birmingham, UK
    Aliment Pharmacol Ther 23:1031-41. 2006
  2. ncbi request reprint Adefovir-lamivudine combination therapy and hepatitis B viral kinetics
    David Mutimer
    J Hepatol 43:200-2. 2005
  3. doi request reprint Understanding the switchbacks: the impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation
    David Mutimer
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom and NIHR Birmingham Liver Biomedical Research Unit, Birmingham, United Kingdom
    Liver Transpl 18:S47-51. 2012
  4. doi request reprint Management of HBV- and HCV-induced end stage liver disease
    David J Mutimer
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Third Floor Nuffield House, Birmingham B15 2TH, UK
    Gut 61:i59-67. 2012
  5. ncbi request reprint The role of antiviral agents in the management of viral hepatitis
    David Mutimer
    University of Birmingham
    Clin Med 6:29-34. 2006
  6. ncbi request reprint Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation
    Ye H Oo
    Liver Research Group, Institute of Biomedical Research, Birmingham, United Kingdom
    Liver Transpl 14:81-7. 2008
  7. ncbi request reprint Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
    Barbara Höroldt
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Int 26:650-9. 2006
  8. ncbi request reprint Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency
    Paul J Gow
    Liver and Hepatobiliary Unit, Third Floor, Nuffield House, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Transpl Int 15:380-3. 2002
  9. ncbi request reprint Adult T-cell leukemia presenting with acute liver failure
    Nicholas Powell
    Liver Unit, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Edgbaston, Birmingham, UK
    Leuk Res 30:1315-7. 2006
  10. ncbi request reprint Outcome of liver transplantation for patients with pulmonary hypertension
    Peter Starkel
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Transpl 8:382-8. 2002

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Review article: hepatitis B and liver transplantation
    D Mutimer
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham University, Birmingham, UK
    Aliment Pharmacol Ther 23:1031-41. 2006
    ..Combination therapy can achieve sustained suppression of viral replication, and hepatitis B e antigen and hepatitis B surface antigen clearance can also be observed...
  2. ncbi request reprint Adefovir-lamivudine combination therapy and hepatitis B viral kinetics
    David Mutimer
    J Hepatol 43:200-2. 2005
  3. doi request reprint Understanding the switchbacks: the impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation
    David Mutimer
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom and NIHR Birmingham Liver Biomedical Research Unit, Birmingham, United Kingdom
    Liver Transpl 18:S47-51. 2012
    ..The blockade of cell surface HCV receptors with antibodies or small molecules appears to limit HCV cell entry in vivo and in a mouse model, and this may suggest a novel approach to limiting HCV recurrence at the time of transplantation...
  4. doi request reprint Management of HBV- and HCV-induced end stage liver disease
    David J Mutimer
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Third Floor Nuffield House, Birmingham B15 2TH, UK
    Gut 61:i59-67. 2012
    ..Though yet to be evaluated in the setting of advanced liver disease, the development of direct acting antivirals for HCV offers hope for improved outcomes at this stage of cirrhosis...
  5. ncbi request reprint The role of antiviral agents in the management of viral hepatitis
    David Mutimer
    University of Birmingham
    Clin Med 6:29-34. 2006
  6. ncbi request reprint Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation
    Ye H Oo
    Liver Research Group, Institute of Biomedical Research, Birmingham, United Kingdom
    Liver Transpl 14:81-7. 2008
    ..Physicians need to be alert to this interaction and to the need to respond quickly to changes in CNI levels that may be associated with HCV infection and with HCV clearance during antiviral therapy...
  7. ncbi request reprint Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection
    Barbara Höroldt
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Int 26:650-9. 2006
    ..The treatment of hepatitis C patients with advanced cirrhotic liver disease remains challenging and data on the outcome of treatment for this patient group is limited...
  8. ncbi request reprint Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency
    Paul J Gow
    Liver and Hepatobiliary Unit, Third Floor, Nuffield House, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Transpl Int 15:380-3. 2002
    ..The patient is alive and well more than 5 years after transplantation. His post-transplant course has been remarkable for the aggressive recurrence then clearance of the HCV...
  9. ncbi request reprint Adult T-cell leukemia presenting with acute liver failure
    Nicholas Powell
    Liver Unit, Queen Elizabeth Hospital, University Hospital Birmingham NHS Trust, Edgbaston, Birmingham, UK
    Leuk Res 30:1315-7. 2006
    ..Liver histology revealed massive infiltration with atypical lymphocytes typical of ATL and liver necrosis...
  10. ncbi request reprint Outcome of liver transplantation for patients with pulmonary hypertension
    Peter Starkel
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Transpl 8:382-8. 2002
    ..Echocardiography detects most severe PHT, but not mild and moderate PHT...
  11. ncbi request reprint The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure
    Wai Kwan Lai
    Liver Laboratories, University of Birmingham, Birmingham, UK
    Intensive Care Med 31:1544-9. 2005
    ..To investigate the effect of the molecular adsorbent recirculating system (MARS) on physiological variables in patients with acute liver failure...
  12. ncbi request reprint Beneficial effect of lamivudine for hepatitis B transplant recipients
    David Mutimer
    Liver Transpl 8:440-2. 2002
  13. ncbi request reprint Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]
    Stephen Barclay
    Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom
    J Clin Virol 42:104-15. 2008
    ..In all these conditions, awareness of possible HBV resistance to therapy must be kept in mind and HBV DNA levels monitored...
  14. ncbi request reprint Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
    Wan Xing Zhang
    Department of Liver Surgery, Hebei Province People s Hospital, Shijiazhuang 050051, China
    Hepatobiliary Pancreat Dis Int 5:154-6. 2006
    ..Lamivudine has been shown to be effective in the treatment of chronic hepatitis B, but resistance to this agent is common after prolonged administration...
  15. ncbi request reprint Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
    Robert Perrillo
    Ochsner Clinic Foundation, New Orleans, LA 70121, USA
    Gastroenterology 126:81-90. 2004
    ..We evaluated the efficacy and safety of adding adefovir dipivoxil to lamivudine in 135 patients with chronic hepatitis B (CHB) and YMDD mutant HBV...
  16. ncbi request reprint Management of antiviral resistance in patients with chronic hepatitis B
    Stephen Locarnini
    Victorian Infectious Diseases Reference Laboratory, North Melbourne, Vic, Australia
    Antivir Ther 9:679-93. 2004
    ..Potential strategies to prevent the emergence of resistance and how to manage drug-resistant HBV once it emerges are discussed...
  17. ncbi request reprint Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation
    John Philpott-Howard
    Department of Infectious Diseases, Guy s, King s and St Thomas School of Medicine, Bessemer Road, London SE5 9PJ, UK
    J Antimicrob Chemother 52:993-1000. 2003
    ..Empirical monotherapy with piperacillin-tazobactam is an effective treatment for infective episodes in liver transplant patients...
  18. doi request reprint The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting
    Stephen Barclay
    Gartnavel General Hospital, 1053 Great Western Road, Glasgow G12 0YN, United Kingdom
    J Clin Virol 41:243-54. 2008
  19. doi request reprint Abdominal wall burns: a late "complication" of liver transplant
    Amit Singhal
    Gastroenterology Unit, Wirral University Teaching Hospital NHS Trust, Wirral, United Kingdom
    Liver Transpl 14:1065-6. 2008
  20. ncbi request reprint Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3
    Paul Gow
    Gastroenterology Unit and Liver Transplant Unit, Austin Hospital, Heidelberg, Victoria, Australia
    J Gastroenterol Hepatol 20:555-61. 2005
    ..The aim of the present paper was to examine a possible human leukocyte antigen (HLA) association with fulminant NANB hepatitis...
  21. ncbi request reprint Modeling costs and cost-effectiveness of different CMV management strategies in liver transplant recipients as a support for current and future decision making
    Lieven Annemans
    Health Economics and Disease Management Meise, Belgium
    Value Health 5:347-58. 2002
    ..To develop a generic decision-analytic model to predict health and economic outcomes of different management options for cytomegalovirus (CMV) infection and disease in liver transplant patients...